These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35940554)

  • 1. Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice.
    Schaefer PM; Huang J; Butic A; Perry C; Yardeni T; Tan W; Morrow R; Baur JA; Wallace DC
    Mol Metab; 2022 Oct; 64():101560. PubMed ID: 35940554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy.
    Palmieri L; Alberio S; Pisano I; Lodi T; Meznaric-Petrusa M; Zidar J; Santoro A; Scarcia P; Fontanesi F; Lamantea E; Ferrero I; Zeviani M
    Hum Mol Genet; 2005 Oct; 14(20):3079-88. PubMed ID: 16155110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of the nicotinamide riboside kinase NAD
    Doig CL; Zielinska AE; Fletcher RS; Oakey LA; Elhassan YS; Garten A; Cartwright D; Heising S; Alsheri A; Watson DG; Prehn C; Adamski J; Tennant DA; Lavery GG
    Skelet Muscle; 2020 Feb; 10(1):5. PubMed ID: 32075690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus-mediated gene transfer of the heart/muscle adenine nucleotide translocator (ANT) in mouse.
    Flierl A; Chen Y; Coskun PE; Samulski RJ; Wallace DC
    Gene Ther; 2005 Apr; 12(7):570-8. PubMed ID: 15647764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliminating the Ant1 isoform produces a mouse with CPEO pathology but normal ocular motility.
    Yin H; Stahl JS; Andrade FH; McMullen CA; Webb-Wood S; Newman NJ; Biousse V; Wallace DC; Pardue MT
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4555-62. PubMed ID: 16303948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator.
    Graham BH; Waymire KG; Cottrell B; Trounce IA; MacGregor GR; Wallace DC
    Nat Genet; 1997 Jul; 16(3):226-34. PubMed ID: 9207786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two new cases of mitochondrial myopathy with exercise intolerance, hyperlactatemia and cardiomyopathy, caused by recessive SLC25A4 mutations.
    Tosserams A; Papadopoulos C; Jardel C; Lemière I; Romero NB; De Lonlay P; Wahbi K; Voermans N; Hogrel JY; Laforêt P
    Mitochondrion; 2018 Mar; 39():26-29. PubMed ID: 28823815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD
    Crisol BM; Veiga CB; Braga RR; Lenhare L; Baptista IL; Gaspar RC; Muñoz VR; Cordeiro AV; da Silva ASR; Cintra DE; Moura LP; Pauli JR; Ropelle ER
    Eur J Nutr; 2020 Sep; 59(6):2427-2437. PubMed ID: 31494696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise.
    Stocks B; Ashcroft SP; Joanisse S; Dansereau LC; Koay YC; Elhassan YS; Lavery GG; Quek LE; O'Sullivan JF; Philp AM; Wallis GA; Philp A
    J Physiol; 2021 Mar; 599(5):1513-1531. PubMed ID: 33492681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men.
    Dollerup OL; Chubanava S; Agerholm M; Søndergård SD; Altıntaş A; Møller AB; Høyer KF; Ringgaard S; Stødkilde-Jørgensen H; Lavery GG; Barrès R; Larsen S; Prats C; Jessen N; Treebak JT
    J Physiol; 2020 Feb; 598(4):731-754. PubMed ID: 31710095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete loss of expression of the ANT1 gene causing cardiomyopathy and myopathy.
    Echaniz-Laguna A; Chassagne M; Ceresuela J; Rouvet I; Padet S; Acquaviva C; Nataf S; Vinzio S; Bozon D; Mousson de Camaret B
    J Med Genet; 2012 Feb; 49(2):146-50. PubMed ID: 22187496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. adPEO mutations in ANT1 impair ADP-ATP translocation in muscle mitochondria.
    Kawamata H; Tiranti V; Magrané J; Chinopoulos C; Manfredi G
    Hum Mol Genet; 2011 Aug; 20(15):2964-74. PubMed ID: 21586654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial energy deficiency leads to hyperproliferation of skeletal muscle mitochondria and enhanced insulin sensitivity.
    Morrow RM; Picard M; Derbeneva O; Leipzig J; McManus MJ; Gouspillou G; Barbat-Artigas S; Dos Santos C; Hepple RT; Murdock DG; Wallace DC
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2705-2710. PubMed ID: 28223503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats.
    Kourtzidis IA; Stoupas AT; Gioris IS; Veskoukis AS; Margaritelis NV; Tsantarliotou M; Taitzoglou I; Vrabas IS; Paschalis V; Kyparos A; Nikolaidis MG
    J Int Soc Sports Nutr; 2016; 13():32. PubMed ID: 27489522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
    Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
    Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide riboside supplementation dysregulates redox and energy metabolism in rats: Implications for exercise performance.
    Kourtzidis IA; Dolopikou CF; Tsiftsis AN; Margaritelis NV; Theodorou AA; Zervos IA; Tsantarliotou MP; Veskoukis AS; Vrabas IS; Paschalis V; Kyparos A; Nikolaidis MG
    Exp Physiol; 2018 Oct; 103(10):1357-1366. PubMed ID: 30007015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3.
    Khan NA; Auranen M; Paetau I; Pirinen E; Euro L; Forsström S; Pasila L; Velagapudi V; Carroll CJ; Auwerx J; Suomalainen A
    EMBO Mol Med; 2014 Jun; 6(6):721-31. PubMed ID: 24711540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adenine nucleotide translocase type 1 (ANT1): a new factor in mitochondrial disease.
    Sharer JD
    IUBMB Life; 2005 Sep; 57(9):607-14. PubMed ID: 16203679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term nicotinamide riboside treatment improves muscle quality and function in mice and increases cellular energetics and differentiating capacity of myogenic progenitors.
    Seldeen KL; Shahini A; Thiyagarajan R; Redae Y; Leiker M; Rajabian N; Dynka A; Andreadis ST; Troen BR
    Nutrition; 2021; 87-88():111189. PubMed ID: 33744645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model.
    Joshi U; Evans JE; Pearson A; Saltiel N; Cseresznye A; Darcey T; Ojo J; Keegan AP; Oberlin S; Mouzon B; Paris D; Klimas N; Sullivan K; Mullan M; Crawford F; Abdullah L
    Neurotoxicology; 2020 Jul; 79():84-94. PubMed ID: 32343995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.